Kevin McKernan

Many of the people in the field will be like, yeah, it's too pure. Who came up with this drug? Epidiolex is from GW Pharma. So they've since been bought by a Japanese company. I'm forgetting its name. But it took them a long time to get that through.

Many of the people in the field will be like, yeah, it's too pure. Who came up with this drug? Epidiolex is from GW Pharma. So they've since been bought by a Japanese company. I'm forgetting its name. But it took them a long time to get that through.

Many of the people in the field will be like, yeah, it's too pure. Who came up with this drug? Epidiolex is from GW Pharma. So they've since been bought by a Japanese company. I'm forgetting its name. But it took them a long time to get that through.

And, of course, the expense of running all the clinical trials and building that business out means when their final product comes out, it's usually five times the price of a CBD oil you can get at a dispensary. Right. So they end up being faced with getting a drug through an expensive process only to turn around and find out there's already a generic out there that's going to mimic it.

And, of course, the expense of running all the clinical trials and building that business out means when their final product comes out, it's usually five times the price of a CBD oil you can get at a dispensary. Right. So they end up being faced with getting a drug through an expensive process only to turn around and find out there's already a generic out there that's going to mimic it.

And, of course, the expense of running all the clinical trials and building that business out means when their final product comes out, it's usually five times the price of a CBD oil you can get at a dispensary. Right. So they end up being faced with getting a drug through an expensive process only to turn around and find out there's already a generic out there that's going to mimic it.

And the only thing they can do is beg the FDA to go and threaten these dispensaries by saying you can't have any medical language or treatment guidelines on your products. That's why you won't see things written on cannabis products saying this is good for headaches or what have you. You're not supposed to list any kind of – um, medical quality, if you will, uh, on, on the label of these products.

And the only thing they can do is beg the FDA to go and threaten these dispensaries by saying you can't have any medical language or treatment guidelines on your products. That's why you won't see things written on cannabis products saying this is good for headaches or what have you. You're not supposed to list any kind of – um, medical quality, if you will, uh, on, on the label of these products.

And the only thing they can do is beg the FDA to go and threaten these dispensaries by saying you can't have any medical language or treatment guidelines on your products. That's why you won't see things written on cannabis products saying this is good for headaches or what have you. You're not supposed to list any kind of – um, medical quality, if you will, uh, on, on the label of these products.

Oh yeah.

Oh yeah.

Oh yeah.

Yeah.

Yeah.

Yeah.

Okay. So, um, Where do we start? My background is a BS in biology from Emory University, and I learned how to do radioactive sequencing when I was there, which I thought was a trick I'd never use again in my life.

Okay. So, um, Where do we start? My background is a BS in biology from Emory University, and I learned how to do radioactive sequencing when I was there, which I thought was a trick I'd never use again in my life.

Okay. So, um, Where do we start? My background is a BS in biology from Emory University, and I learned how to do radioactive sequencing when I was there, which I thought was a trick I'd never use again in my life.

And it turned out shortly after I did maybe a nine or 10-month stint at a company doing pharmaceutical marketing, I decided I want to get back to the bench and luckily got into the Human Genome Project up in Cambridge at MIT. my resume ended up on Trevor Hawkins desk from two different people at once. Um, for some bizarre reason, he hired me.

And it turned out shortly after I did maybe a nine or 10-month stint at a company doing pharmaceutical marketing, I decided I want to get back to the bench and luckily got into the Human Genome Project up in Cambridge at MIT. my resume ended up on Trevor Hawkins desk from two different people at once. Um, for some bizarre reason, he hired me.